Veeva Vault CTMS Launches at Bristol Myers Squibb


Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management. The new CTMS replaced a heritage Celgene CTMS and a heritage Bristol Myers Squibb CTMS and is tightly integrated with Veeva’s eTMF and Study Startup applications. The total implementation time was less than 20 months.

Read more about the launch here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.